✦ LIBER ✦

Assessment of the item selection and weighting in the Birmingham Vasculitis Activity Score for Wegener's Granulomatosis

✍ Scribed by Mahr, Alfred D. ;Neogi, Tuhina ;Lavalley, Michael P. ;Davis, John C. ;Hoffman, Gary S. ;Mccune, W. Joseph ;Specks, Ulrich ;Spiera, Robert F. ;St.Clair, E. William ;Stone, John H. ;Merkel, Peter A. ;,

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 117 KB
Volume: 59
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.23707

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A disease-specific activity index for We

A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score

✍ John H. Stone; Gary S. Hoffman; Peter A. Merkel; Yuan-I Min; Misty L. Uhlfelder; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Sjögren's syndrome disease damage index

Sjögren's syndrome disease damage index and disease activity index: Scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients

✍ Claudio Vitali; Gianluigi Palombi; Chiara Baldini; Maurizio Benucci; Stefano Bom 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

## Abstract ## Objective To develop valid instruments for the assessment of disease‐related damage and disease activity in Sjögren's syndrome (SS). ## Methods Data on 206 patients with primary SS were collected in 12 Italian centers. Each patient was scored by 1 investigator, on the basis of a g

The Disease Activity Score is not suitab

The Disease Activity Score is not suitable as the sole criterion for initiation and evaluation of anti–tumor necrosis factor therapy in the clinic: Discordance between assessment measures and limitations in questionnaire use for regulatory purposes

✍ Frederick Wolfe; Kaleb Michaud; Theodore Pincus; Daniel Furst; Edward Keystone 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 2 views

## Abstract ## Objective The Disease Activity Score (DAS) is widely used in clinical trials. A DAS of 5.1 defines the level of severe rheumatoid arthritis (RA) and is the criterion for the initiation of anti–tumor necrosis factor therapy in the UK and The Netherlands. In North America, similar rul

Measures of symptoms and disease status

Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S)

✍ Jane Zochling 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 113 KB 👁 2 views